Status:
COMPLETED
miRNA Machinery in Melanoma, Melanoma Metastases and Benign Melanocytic Naevi
Lead Sponsor:
Ruhr University of Bochum
Conditions:
Cutaneous Melanoma
Nevi
Eligibility:
All Genders
1+ years
Brief Summary
MicroRNAs (miRNAs) are very small endogenous RNA molecules about 22-25 nucleotides in length, capable of post-transcriptional gene regulation. miRNAs bind to their target messenger RNAs (mRNAs), leadi...
Detailed Description
Patients with cutaneous melanoma, cutaneous melanoma metastases and benign melanocytic nevi were included in the study. Punch biopsies were harvested from the center of the tumors. The miRNA machinery...
Eligibility Criteria
Inclusion
- cutaneous melanoma
- cutaneous melanoma metastases
- benign melanocytic nevi
Exclusion
- other forms of malignancy
Key Trial Info
Start Date :
December 1 2008
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
September 1 2011
Estimated Enrollment :
21 Patients enrolled
Trial Details
Trial ID
NCT01444560
Start Date
December 1 2008
End Date
September 1 2011
Last Update
October 16 2012
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Department of Dermatology, Venereology and Allergology, Ruhr-University Bochum
Bochum, North Rhine-Westphalia, Germany, 44791